In contrast to their marked activity in invertebrate HD models, pan-HDAC inhibitors like SAHA (suberoylanilide hydroxamic acid) or phenyl butyrate have shown only modest efficacy in mouse models [3], [5], [15]. The gene discussed is HDAC9; the disease is Huntington disease.